Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response

Breast Cancer Research

Volumn 15, Issue 1, 2013, Pages

  Nagelkerke, Anika ^a   Bussink, Johan ^a   Mujcic, Hilda ^b,c   Wouters, Bradly G ^b,c   Lehmann, Steffi ^a   Sweep, Fred C G J ^a   Span, Paul N ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; COLLAGEN; DENDRITIC CELL LYSOSOME ASSOCIATED MEMBRANE PROTEIN; MESSENGER RNA; PHOSPHOTRANSFERASE; PKR LIKE ENDOPLASMIC RETICULUM KINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ATF4 PROTEIN, HUMAN; EIF2AK3 PROTEIN, HUMAN; LAMP3 PROTEIN, HUMAN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN; PROTEIN KINASE R; TUMOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER PROGNOSIS; CELL GROWTH; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; GENE SILENCING; HYPOXIA; IN VITRO STUDY; METASTASIS; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR MICROENVIRONMENT; TUMOR SPHEROID; UNFOLDED PROTEIN RESPONSE; BIOSYNTHESIS; BREAST TUMOR; CELL HYPOXIA; CELL MOTION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ACTIVATING TRANSCRIPTION FACTOR 4; BREAST NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; EIF-2 KINASE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE;

EID: 84871882783     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3373     Document Type: Article

References (50)

1. Weigelt B, Peterse JL, Van't Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer 2005, 5:591-602.
2. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674. 10.1016/j.cell.2011.02.013, 21376230.
3. Friedl P, Locker J, Sahai E, Segall JE. Classifying collective cancer cell invasion. Nat Cell Biol 2012, 14:777-783. 10.1038/ncb2548, 22854810.
4. Brown JM. Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol 1979, 52:650-656. 10.1259/0007-1285-52-620-650, 486895.
5. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955, 9:539-549. 10.1038/bjc.1955.55, 2073776, 13304213.
6. Rademakers SE, Span PN, Kaanders JH, Sweep FC, Van Der Kogel AJ, Bussink J. Molecular aspects of tumour hypoxia. Mol Oncol 2008, 2:41-53. 10.1016/j.molonc.2008.03.006, 19383328.
7. Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1997, 38:285-289. 10.1016/S0360-3016(97)00101-6, 9226314.
8. Hockel M, Schlenger K, Hockel S, Vaupel P. Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res 1999, 59:4525-4528.
9. Kaanders JH, Wijffels KI, Marres HA, Ljungkvist AS, Pop LA, Van Den Hoogen FJ, de Wilde PC, Bussink J, Raleigh JA, Van Der Kogel AJ. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res 2002, 62:7066-7074.
10. Bussink J, Kaanders JH, Van Der Kogel AJ. Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol 2003, 67:3-15. 10.1016/S0167-8140(03)00011-2, 12758235.
11. Chia SK, Wykoff CC, Watson PH, Han C, Leek RD, Pastorek J, Gatter KC, Ratcliffe P, Harris AL. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol 2001, 19:3660-3668.
12. Span PN, Bussink J, Manders P, Beex LV, Sweep CG. Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcome. Br J Cancer 2003, 89:271-276. 10.1038/sj.bjc.6601122, 2394253, 12865916.
13. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996, 56:4509-4515.
14. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996, 41:31-39.
15. Sundfor K, Lyng H, Rofstad EK. Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. Br J Cancer 1998, 78:822-827. 10.1038/bjc.1998.586, 2062967, 9743308.
16. Chan DA, Giaccia AJ. Hypoxia, gene expression, and metastasis. Cancer Metastasis Rev 2007, 26:333-339. 10.1007/s10555-007-9063-1, 17458506.
17. Chaudary N, Hill RP. Hypoxia and metastasis in breast cancer. Breast Dis 2006, 26:55-64.
18. Gort EH, Groot AJ, Van Der Wall E, van Diest PJ, Vooijs MA. Hypoxic regulation of metastasis via hypoxia-inducible factors. Curr Mol Med 2008, 8:60-67. 10.2174/156652408783565568, 18289014.
19. Le QT, Denko NC, Giaccia AJ. Hypoxic gene expression and metastasis. Cancer Metastasis Rev 2004, 23:293-310.
20. Lunt SJ, Chaudary N, Hill RP. The tumor microenvironment and metastatic disease. Clin Exp Metastasis 2009, 26:19-34. 10.1007/s10585-008-9182-2, 18543068.
21. Koumenis C, Naczki C, Koritzinsky M, Rastani S, Diehl A, Sonenberg N, Koromilas A, Wouters BG. Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha. Mol Cell Biol 2002, 22:7405-7416. 10.1128/MCB.22.21.7405-7416.2002, 135664, 12370288.
22. Feldman DE, Chauhan V, Koong AC. The unfolded protein response: a novel component of the hypoxic stress response in tumors. Mol Cancer Res 2005, 3:597-605. 10.1158/1541-7786.MCR-05-0221, 16317085.
23. Koumenis C, Wouters BG. "Translating" tumor hypoxia: unfolded protein response (UPR)-dependent and UPR-independent pathways. Mol Cancer Res 2006, 4:423-436. 10.1158/1541-7786.MCR-06-0150, 16849518.
24. Wouters BG, Koritzinsky M. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer 2008, 8:851-864. 10.1038/nrc2501, 18846101.
25. Rouschop KM, Van Den Beucken T, Dubois L, Niessen H, Bussink J, Savelkouls K, Keulers T, Mujcic H, Landuyt W, Voncken JW, Lambin P, Van Der Kogel AJ, Koritzinsky M, Wouters BG. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J Clin Invest 2010, 120:127-141. 10.1172/JCI40027, 2798689, 20038797.
26. Mujcic H, Rzymski T, Rouschop KM, Koritzinsky M, Milani M, Harris AL, Wouters BG. Hypoxic activation of the unfolded protein response (UPR) induces expression of the metastasis-associated gene LAMP3. Radiother Oncol 2009, 92:450-459. 10.1016/j.radonc.2009.08.017, 19726095.
27. Ozaki K, Nagata M, Suzuki M, Fujiwara T, Ueda K, Miyoshi Y, Takahashi E, Nakamura Y. Isolation and characterization of a novel human lung-specific gene homologous to lysosomal membrane glycoproteins 1 and 2: significantly increased expression in cancers of various tissues. Cancer Res 1998, 58:3499-3503.
28. Nagelkerke A, Mujcic H, Bussink J, Wouters BG, van Laarhoven HW, Sweep FC, Span PN. Hypoxic regulation and prognostic value of LAMP3 expression in breast cancer. Cancer 2011, 117:3670-3681. 10.1002/cncr.25938, 21319150.
29. Saitoh O, Wang WC, Lotan R, Fukuda M. Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem 1992, 267:5700-5711.
30. Sawada R, Lowe JB, Fukuda M. E-selectin-dependent adhesion efficiency of colonic carcinoma cells is increased by genetic manipulation of their cell surface lysosomal membrane glycoprotein-1 expression levels. J Biol Chem 1993, 268:12675-12681.
31. Kanao H, Enomoto T, Kimura T, Fujita M, Nakashima R, Ueda Y, Ueno Y, Miyatake T, Yoshizaki T, Buzard GS, Tanigami A, Yoshino K, Murata Y. Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer. Cancer Res 2005, 65:8640-8645. 10.1158/0008-5472.CAN-04-4112, 16204031.
32. Mazure NM, Pouyssegur J. Hypoxia-induced autophagy: cell death or cell survival?. Curr Opin Cell Biol 2010, 22:177-180. 10.1016/j.ceb.2009.11.015, 20022734.
33. Canning MT, Postovit LM, Clarke SH, Graham CH. Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells. Exp Cell Res 2001, 267:88-94. 10.1006/excr.2001.5243, 11412041.
34. Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, Le QT, Chi JT, Jeffrey SS, Giaccia AJ. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 2006, 440:1222-1226. 10.1038/nature04695, 16642001.
35. Funasaka T, Yanagawa T, Hogan V, Raz A. Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia. FASEB J 2005, 19:1422-1430. 10.1096/fj.05-3699com, 16126909.
36. Graham CH, Forsdike J, Fitzgerald CJ, Macdonald-Goodfellow S. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int J Cancer 1999, 80:617-623. 10.1002/(SICI)1097-0215(19990209)80:4<617::AID-IJC22>3.0.CO;2-C, 9935166.
37. Indelicato M, Pucci B, Schito L, Reali V, Aventaggiato M, Mazzarino MC, Stivala F, Fini M, Russo MA, Tafani M. Role of hypoxia and autophagy in MDA-MB-231 invasiveness. J Cell Physiol 2010, 223:359-368.
38. Postovit LM, Adams MA, Lash GE, Heaton JP, Graham CH. Oxygen-mediated regulation of tumor cell invasiveness. Involvement of a nitric oxide signaling pathway. J Biol Chem 2002, 277:35730-35737. 10.1074/jbc.M204529200, 12107174.
39. Fels DR, Koumenis C. The PERK/eIF2alpha/ATF4 module of the UPR in hypoxia resistance and tumor growth. Cancer Biol Ther 2006, 5:723-728.
40. Koritzinsky M, Magagnin MG, Van Den Beucken T, Seigneuric R, Savelkouls K, Dostie J, Pyronnet S, Kaufman RJ, Weppler SA, Voncken JW, Lambin P, Koumenis C, Sonenberg N, Wouters BG. Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. EMBO J 2006, 25:1114-1125. 10.1038/sj.emboj.7600998, 1409715, 16467844.
41. Reshkin SJ, Bellizzi A, Albarani V, Guerra L, Tommasino M, Paradiso A, Casavola V. Phosphoinositide 3-kinase is involved in the tumor-specific activation of human breast cancer cell Na(+)/H(+) exchange, motility, and invasion induced by serum deprivation. J Biol Chem 2000, 275:5361-5369. 10.1074/jbc.275.8.5361, 10681510.
42. Munoz-Najar UM, Neurath KM, Vumbaca F, Claffey KP. Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation. Oncogene 2006, 25:2379-2392. 10.1038/sj.onc.1209273, 16369494.
43. Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003, 3:347-361. 10.1016/S1535-6108(03)00085-0, 12726861.
44. Krohn A, Song YH, Muehlberg F, Droll L, Beckmann C, Alt E. CXCR4 receptor positive spheroid forming cells are responsible for tumor invasion in vitro. Cancer Lett 2009, 280:65-71. 10.1016/j.canlet.2009.02.005, 19286309.
45. de Saint-Vis B, Vincent J, Vandenabeele S, Vanbervliet B, Pin JJ, Ait-Yahia S, Patel S, Mattei MG, Banchereau J, Zurawski S, Davoust J, Caux C, Lebecque S. A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity 1998, 9:325-336. 10.1016/S1074-7613(00)80615-9, 9768752.
46. Zhou Z, Xue Q, Wan Y, Yang Y, Wang J, Hung T. Lysosome-associated membrane glycoprotein 3 is involved in influenza A virus replication in human lung epithelial (A549) cells. Virol J 2011, 8:384. 10.1186/1743-422X-8-384, 3162545, 21810281.
47. Eskelinen EL. Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol Aspects Med 2006, 27:495-502. 10.1016/j.mam.2006.08.005, 16973206.
48. Macintosh RL, Timpson P, Thorburn J, Anderson KI, Thorburn A, Ryan KM. Inhibition of autophagy impairs tumor cell invasion in an organotypic model. Cell Cycle 2012, 11:2022-2029. 10.4161/cc.20424, 3359125, 22580450.
49. Vigneswaran N, Wu J, Song A, Annapragada A, Zacharias W. Hypoxia-induced autophagic response is associated with aggressive phenotype and elevated incidence of metastasis in orthotopic immunocompetent murine models of head and neck squamous cell carcinomas (HNSCC). Exp Mol Pathol 2011, 90:215-225. 10.1016/j.yexmp.2010.11.011, 3057178, 21236253.
50. Lazova R, Camp RL, Klump V, Siddiqui SF, Amaravadi RK, Pawelek JM. Punctate LC3B expression is a common feature of solid tumors and associated with proliferation, metastasis, and poor outcome. Clin Cancer Res 2012, 18:370-379. 10.1158/1078-0432.CCR-11-1282, 22080440.